Editorial Board Award – Human Immunology

10/05/2022

Each year, the Human Immunology editorial board awards the best original research papers and the best review papers from two years previous. The top papers in each category published in 2020 were chosen based on citation and download statistics gathered from 2021. The papers were then voted on by...

Doug Bost became a member of the Scientific Advisory Board for Digital PCR at QIAGEN

10/05/2022

Omixon is entering the field of post-transplant monitoring. To ensure its position in the market our company has entered a strategic partnership with Organ Monitoring Group (OMG) founded by Doug Bost to bring our newest product, HoloGRAFT, to market. Doug Bost joined Omixon in the position of VP of...

NanoTYPE HLA – A New Era of HLA Typing

10/05/2022

Written by Libor Kolesár, PhD HLA tissue typing is like a constantly changing and evolving organism. During the era of SSP and SSOP methods, Sanger-based typing (SBT) was developed and quickly became the gold standard. SBT had several advantages over SNP-based methods (SSP and SSOP) as it was not...

EFI 2022

10/05/2022

EFI 2022 | Tolerance, Acceptance and Permissiveness After 2 long years, the opportunity to meet and greet is open again in the event of the 35th EFI Annual Meeting in Amsterdam. Our team is very excited to meet many people from the field again in person. We...

Renewed Omixon Monthly Newsletter

09/05/2022

We are thrilled to announce that Omixon’s monthly newsletter has been renewed. We keep continuously delivering fresh news of HLA research, genetics and immunogenetics to our readers, but we are going to wrap this info package into a new format. The revamped newsletter contains more visual elements and less...